Back to Search
KAREN PRICE, PHD
PHD
Clinical Psychologist
NPI: 1205802030Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.
PMID 19633051·Ann Oncol·2010
4-observational
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.
PMID 19474112·Ann Oncol·2009
3-trial
Pneumolysin localizes to the cell wall of Streptococcus pneumoniae.
PMID 19168620·J Bacteriol·2009
7-preclinical
Chemoradiation for unresectable stage III non-small cell lung cancer.
PMID 19038729·Semin Thorac Cardiovasc Surg·2008
6-review
A hydrogen bond in loop A is critical for the binding and function of the 5-HT3 receptor.
PMID 18498149·Biochemistry·2008
7-preclinical
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer.
PMID 18385202·Ann Oncol·2008
2-rct
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
PMID 18325918·Ann Oncol·2008
8-other
Debating the influence of self-reports by people living with chronic disease on healthy aging and longevity.
PMID 17986579·Ann N Y Acad Sci·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2910 HARRIS ST
EUREKA, CA 95503 - Phone
- (707) 269-0812
Quick Facts
- NPI
- 1205802030
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile